Quick Answer
Oaktree Acquisition Corp. III Life Sciences reported Net Income of $7.29 million for fiscal year 2025.
Oaktree Acquisition Corp. III Life Sciences Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $7.29M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.97M | +4189.3% | +4.9% |
| June 30, 2025 | $1.87M | — | +13.0% |
| March 31, 2025 | $1.66M | — | +3549.0% |
| September 30, 2024 | -$48.1K | — | — |
| June 30, 2024 | $0.00 | — | — |
- The most recent figure is from Oaktree Acquisition Corp. III Life Sciences’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: